new med for type 2 diabetes, Avandia (rosiglitazone)

June 1999

You'll see a new med for type 2 diabetes, Avandia (rosiglitazone).

It's a new "glitazone"...similar to Rezulin (troglitazone). A third one, Actos (pioglitazone) will be out later this summer.

These new drugs come at a good time...with all the concern about hepatotoxicity from Rezulin.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote